Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

569 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High detection rate of circulating-tumor DNA from cerebrospinal fluid of children with central nervous system germ cell tumors.
Nakano Y, Burns I, Nobre L, Siddaway R, Rana M, Nesvick C, Bondoc A, Ku M, Yuditskiy R, Ku DTL, Shing MMK, Cheng KKF, Ng HK, Das A, Bennett J, Ramaswamy V, Huang A, Malkin D, Ertl-Wagner B, Dirks P, Bouffet E, Bartels U, Tabori U, Hawkins C, Liu APY. Nakano Y, et al. Among authors: ku m. Acta Neuropathol Commun. 2024 Nov 20;12(1):178. doi: 10.1186/s40478-024-01886-w. Acta Neuropathol Commun. 2024. PMID: 39568077 Free PMC article.
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: ku m. Lancet. 2024 Nov 16;404(10466):1940-1954. doi: 10.1016/S0140-6736(24)01774-4. Lancet. 2024. PMID: 39550172 Clinical Trial.
EFP Analyzer: A fast, accurate, and easy-to-teach program for analyzing Extracellular Field Potentials from iPSC-derived cardiomyocytes.
Patel N, Shen A, Wada Y, Blair M, Mitchell D, Vanags L, Woo S, Ku M, Dauda K, Morris W, Yang M, Knollmann BC, Roden DM, Salem JE, Glazer AM, Kroncke BM. Patel N, et al. Among authors: ku m. bioRxiv [Preprint]. 2024 Oct 24:2024.10.21.619481. doi: 10.1101/2024.10.21.619481. bioRxiv. 2024. PMID: 39484468 Free PMC article. Preprint.
Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies.
Sehn LH, Bartlett NL, Matasar MJ, Schuster SJ, Assouline SE, Giri P, Kuruvilla J, Shadman M, Cheah CY, Dietrich S, Fay K, Ku M, Nastoupil LJ, Wei MC, Yin S, To I, Kaufman D, Kwan A, Penuel E, Bolen CR, Budde LE. Sehn LH, et al. Among authors: ku m. Blood. 2024 Oct 24:blood.2024025454. doi: 10.1182/blood.2024025454. Online ahead of print. Blood. 2024. PMID: 39447094
Correction: Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer.
Hwang J, Park A, Kim C, Kim CG, Kwak J, Kim B, Shin H, Ku M, Yang J, Baek A, Choi J, Lim H, No KT, Zhao X, Choi U, Kim TI, Jeong KS, Lee H, Shin SJ. Hwang J, et al. Among authors: ku m. Cell Commun Signal. 2024 Oct 7;22(1):480. doi: 10.1186/s12964-024-01840-2. Cell Commun Signal. 2024. PMID: 39375681 Free PMC article. No abstract available.
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma.
Maakaron JE, Asch A, Popplewell L, Collins GP, Flinn IW, Ghosh N, Keane C, Ku M, Mehta A, Roschewski M, Hacohen-Kleiman G, Huo Y, Zhang Y, Renard C, Smith SM, Advani R. Maakaron JE, et al. Among authors: ku m. Blood Adv. 2024 Nov 26;8(22):5864-5874. doi: 10.1182/bloodadvances.2024013338. Blood Adv. 2024. PMID: 39293083 Clinical Trial.
569 results